Evidence
[1] Original publication
Lip GYH, Nieuwlaat R, Pisters R, Lane DA, Crijns HJGM. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach.
Chest, 2010
[2] Validation
Olesen JB, Lip GYH, Hansen ML, et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. CHA₂DS₂-VASc reliably identifies patients who are truly low risk.
BMJ, 2011
[3] Guideline
Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation (developed with EACTS). This app uses the guideline-era sex-aware CHA₂DS₂-VASc score categories.
European Heart Journal, 2021
[4] Further source
Van Gelder IC, Rienstra M, Bunting KV, et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.
European Heart Journal, 2024
Last reviewed: 2026-09
Report an error in this calculator